Clinical trial
Patient Preferences and Efficacy of TOBI Podhaler vs. Tobramycin Inhalation Solution (PETIS)
NCT02038803 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patient Preferences and Efficacy of TOBI Podhaler vs. Tobramycin Inhalation Solution (PETIS)
- Lead sponsor
- Rush University Medical Center
- Phase
- Observational
- Overall status
- Terminated
- Start date
- October 10, 2013
- Completion date
- May 7, 2014
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.